Crossmark

Genetically proxied therapeutic effect of antihypertensive drug use, breast cancer, and ovarian cancer’s risk: a drug-target Mendelian randomization study

Crossref DOI link: https://doi.org/10.1186/s12885-025-14350-2

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dang, Chunxiao

Wang, Ruohan

Shi, Yunzhen

Liu, Pengfei

Wang, Xiaofeng

Liu, Jinxing

Yu, Xiao

Jin, Dongxu

Ma, Qing
Funding

Funding for this research was provided by:

Natural Science Foundation of Shandong Province (ZR2021MH079)

National Natural Science Foundation of China (82104917)

Key Project of Medicine and Health of Shandong Province (202312070996)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 3 February 2024

Accepted: 19 May 2025

First Online: 1 July 2025

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below